Stratos Wealth Advisors, LLC - PHATHOM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Stratos Wealth Advisors, LLC ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129,625
-27.6%
12,5000.0%0.01%
-30.8%
Q2 2023$179,000
+100.6%
12,5000.0%0.01%
+85.7%
Q1 2023$89,25012,5000.01%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 4,901,358$41,368,0008.59%
Frazier Life Sciences Management, L.P. 5,827,415$49,183,0004.64%
Abingworth LLP 1,435,106$12,112,0003.88%
Penn Mutual Asset Management 86,940$734,0000.99%
683 Capital Management, LLC 1,440,000$12,153,0000.86%
Western Standard LLC 109,055$920,0000.70%
MPM BioImpact LLC 193,326$1,632,0000.45%
Newtyn Management, LLC 255,767$2,159,0000.41%
StepStone Group LP 422,085$3,562,0000.38%
Avidity Partners Management LP 1,919,800$16,203,0000.37%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders